Navigation Links
Jerusalem Global Ventures Announces $200 Million Growth Equity Fund

JERUSALEM, November 29 /PRNewswire/ -- Jerusalem Global Ventures today announced that it will soon be launching JGV Growth Equity Fund, L.P., a $200 million fund. The Fund will invest in private Israeli related technology companies that are on a trajectory to IPO within three years and have a proven business model. First closing is scheduled for April 2008.

Dr. Shlomo Kalish, who founded Jerusalem Global in 1994, notes that, "Unlike the early stage VC investment model, where one expects multiple write-offs for every 'home run', this Fund's business model should produce quicker turnaround of money, lower risk, and more predictable returns." In 2007, Dr. Kalish was the only Israeli in the Top 50 of the Forbes Midas list.

Jerusalem Global currently manages two sector funds launched in 1999. When compared to peers of the same vintage, one of those funds is at the top in terms of both cash distribution and IRR. Jerusalem Global's spokesman said, "We believe the record of the second fund will be as good or better when the remaining portfolio companies are exited."

Dr. Yoseph Linde, who co-managed the prior Funds, commented, "Over the last several years, in the course of making investments for our early-stage VC fund, we were offered numerous opportunities to invest in late-stage technology companies. Although we rejected most of these offers as they did not fit our primarily early stage focus, we did make two such investments resulting in two successful exits. Our portfolio company, Mellanox, which had a successful IPO earlier this year, would be a perfect example of companies we'd fund." Dr. Linde was a successful serial entrepreneur before joining Jerusalem Global Ventures.

The Fund expects to invest $5-20 million in companies which late-stage financing needs of $10-50 million. Dr. Kalish said, "Think of this Fund as a barbell. On one end we have foreign financial institutions that do not have staff on the ground in Israel but have expressed interest in co-investing with us. On the other end we have investment banks that would like to establish a strategic relationship in order to help prepare our portfolio companies for an IPO. The Fund is the connecting rod in the middle, using the manager's network and expertise to source and invest in quality deals."

Dr. Kalish added, "There are some interesting things going on in Israeli technology. The number of private companies with revenue of more than $10 million has exploded, and we see more in the pipeline. Yet, there is still pressure for such firms to exit too early. This Fund will help successful companies bridge that gap and get to a point where they can realize their full value."

A number of investors in the prior fund have committed to this Fund. In addition, Jerusalem Global will be marketing the Fund to major financial institutions, fund of funds, university endowments, and pension funds.

About Jerusalem Global Ventures

Jerusalem Global began in 1994 and was soon recognized as the leading technology investment bank in Israel. It produced an IRR to investors of 84%, and underwrote some of the largest offerings in Israel, including Galileo and Creo. The prior fund, mentioned above, was begun in 1999 and also had some notable exits, including Mellanox and Kashya.

Drs. Kalish and Linde, the senior investment professionals, have been together over nine years. Rounding out the investment team are Ranan Grobman, who has been with the Firm for five years, and Shlomo Caine, former Managing Director of Intel Capital (Israel), who has joined as a Venture Partner. Robbie Citron is the CFO, and Paul Lowenstein has joined the firm as Director of Investor Relations.


Dr. Shlomo Kalish or Paul Lowenstein, through, or at +972-2-649-0750.

SOURCE Jerusalem Global Ventures Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
(Date:10/11/2017)... ... 11, 2017 , ... Disappearing forests and increased emissions are the main causes ... each year. Especially those living in larger cities are affected by air pollution related ... the most pollution-affected countries globally - decided to take action. , “I knew I ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand ... Excellence in Volunteer Experience from US2020. , US2020’s mission is to change the ...
(Date:10/10/2017)... ... October 10, 2017 , ... The ... prestigious awards honoring scientists who have made outstanding contributions to analytical ... during Pittcon 2018, the world’s leading conference and exposition for laboratory science, which ...
(Date:10/9/2017)... (PRWEB) , ... October 09, ... ... published on October 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s ... the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) using ...
Breaking Biology Technology:
(Date:5/16/2017)... TEANECK, N.J. , May 16, 2017  Veratad ... leading provider of online age and identity verification solutions, ... the K(NO)W Identity Conference 2017, May 15 thru May ... Ronald Regan Building and International Trade Center. ... across the globe and in today,s quickly evolving digital ...
(Date:4/19/2017)... 2017 The global military biometrics ... marked by the presence of several large global players. ... five major players - 3M Cogent, NEC Corporation, M2SYS ... nearly 61% of the global military biometric market in ... global military biometrics market boast global presence, which has ...
(Date:4/13/2017)... -- According to a new market research report "Consumer IAM ... and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global ... grow from USD 14.30 Billion in 2017 to USD 31.75 Billion by ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):